ENPP2 and cancer: The above studies demonstrate that hypermethylation of ENPP2 promoter and 1st Exon in cancer is correlated with reduced ATX expression, presenting an epigenetic expression regulation level, and suggests a potential of ENPP2 methylation as a prognostic biomarker, awaiting further validation.